Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 11;27(16):4599–4609. doi: 10.1158/1078-0432.CCR-21-0205

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2021 The Authors; Published by the American Association for Cancer Research

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs International 4.0 License.

PMC Copyright notice

Figure 4. Immune correlates of recurrence following BCG treatment. A, Volcano plot demonstrating correlation of expression of individual immune-related genes with probability of remaining free of a high-grade recurrence beyond 24 months after BCG (only genes statistically significant after Benjamini–Hochberg false discovery correction are in red and labeled). RFS by PD-L1 (CD274) expression among BCG-treated MSK patients (B) and patients in the UROMOL cohort (C). — Immune correlates of recurrence following BCG treatment. A, Volcano plot demonstrating correlation of expression of individual immune-related genes with probability of remaining free of a high-grade recurrence beyond 24 months after BCG (only genes statistically significant after Benjamini–Hochberg false discovery correction are in red and labeled). RFS by PD-L1 (CD274) expression among BCG-treated MSK patients (B) and patients in the UROMOL cohort (C).